8-K Filing

Company

IGC Pharma, Inc.

Filed

April 6, 2012

Period of Report

April 5, 2012

Accession Number

0001185185-12-000718

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →